Mirati Therapeutics (MRTX) – New Coverage
-
Piper Sandler Assumes Mirati Therapeutics (MRTX) at Overweight
-
Scotiabank Starts Mirati Therapeutics (MRTX) at Sector Underperform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to MRTX Stock Lookup